Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD) Short Interest Update

Posted by Andrew Walz on Oct 19th, 2025

Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD – Get Free Report) saw a large drop in short interest during the month of September. As of September 30th, there was short interest totaling 148,500 shares, a drop of 86.5% from the September 15th total of 1,100,000 shares. Based on an average daily volume of 1,660,500 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 1,660,500 shares, the short-interest ratio is currently 0.1 days.

Direxion Daily S&P Biotech Bear 3x Shares Stock Performance

NYSEARCA LABD opened at $32.34 on Friday. The company’s fifty day moving average is $47.77 and its two-hundred day moving average is $70.07. Direxion Daily S&P Biotech Bear 3x Shares has a 52-week low of $29.54 and a 52-week high of $160.50.

Institutional Trading of Direxion Daily S&P Biotech Bear 3x Shares

Several hedge funds and other institutional investors have recently bought and sold shares of LABD. Jump Financial LLC grew its position in Direxion Daily S&P Biotech Bear 3x Shares by 107.7% in the 2nd quarter. Jump Financial LLC now owns 174,239 shares of the company’s stock worth $1,303,000 after purchasing an additional 90,333 shares during the last quarter. Group One Trading LLC acquired a new stake in Direxion Daily S&P Biotech Bear 3x Shares in the 2nd quarter worth $337,000. Tower Research Capital LLC TRC grew its position in Direxion Daily S&P Biotech Bear 3x Shares by 87.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 41,202 shares of the company’s stock worth $308,000 after purchasing an additional 19,276 shares during the last quarter. Finally, Envestnet Asset Management Inc. acquired a new stake in Direxion Daily S&P Biotech Bear 3x Shares in the 2nd quarter worth $84,000.